Table 5.
Deaths | Mortality rate | Relative risk, p-value | ||
---|---|---|---|---|
12 months | HBPC | 31 | 15% | 1.56 p = 0.182 |
Control | 21 | 10% | ||
24 months | HBPC | 42 | 20% | 1.21 |
Control | 36 | 17% | p = 0.531 |
Table 5 provides mortality rates and relative risks of HBPC participants relative to controls. HBPC participants show slightly but insignificantly greater mortality rates, likely due to unmatched criteria used to select HBPC participants